Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma

NCT03542266

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Weill Cornell Medicine New York, United States
View Trial Details
Completed

Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

NCT00039130

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • Naval Medical Center - San Diego San Diego, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 31 locations
View Trial Details
Completed

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

NCT02034110

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Blood Protein Disorders, +35 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Santa Monica, California, United States
  • Novartis Investigative Site Bethesda, Maryland, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View all 41 locations
View Trial Details
Completed

Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma

NCT01484093

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States
View Trial Details
Completed

A Study for Older Adults With Acute Lymphoblastic Leukaemia

NCT01616238

Conditions
Acute Lymphoblastic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Erasmus MC Rotterdam, Netherlands
  • NHS Lanarkshire - Monklands Airdrie, United Kingdom
  • Blackpool Victoria Hopsital Blackpool, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
View all 34 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat

NCT03982225

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Yonsei University Health System, Severance Hospital Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
  • Yonsei University Health System, Gangnam Severance Hospital Seoul, South Korea
View Trial Details

Related conditions